Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis
Conditions: Drug-resistant Tuberculosis; HIV Coinfection; Cost-Benefit Analysis Intervention: Diagnostic Test: Targeted next-generation sequencing Sponsors: University of California, San Francisco; University of Stellenbosch; National Health Laboratory Service (NHLS), South Africa; National Institute for Communicable Diseases, South Africa; National Institute of Allergy and Infectious Diseases (NIAID); Find; Translational Ge nomics Research Institute; University Hospital Heidelberg Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: African Health | Allergy | Allergy & Immunology | Infectious Diseases | Laboratory Medicine | Research | South Africa Health | Tuberculosis